New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.
about
Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasAutologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomasAutologous haematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas: a Cochrane systematic review*Oral and dental late effects in survivors of childhood cancer: a Children's Oncology Group reportSecondary solid cancer screening following hematopoietic cell transplantationNational Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Subsequent NeoplasmsPediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Glioblastoma Multiforme in a Post Allogeneic Stem Cell Transplant Patient. A Case Report and Literature Review of Post Transplant Neurological TumorsDrug-induced hematologic syndromesHematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.Donor-transmitted melanoma after limbal stem cell transplantationReduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastomaModern approaches to pediatric brain injury therapy.Donor-derived second hematologic malignancies after cord blood transplantation.Radiosensitive severe combined immunodeficiency disease.The role of social and cognitive processes in the relationship between fear network and psychological distress among parents of children undergoing hematopoietic stem cell transplantationSecond solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioningLate effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control studySecondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.Busulfan in hematopoietic stem cell transplantationSubsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review.Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort studyOral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomesPsychological distress and psychiatric diagnoses among primary caregivers of children undergoing hematopoietic stem cell transplant: an examination of prevalence, correlates, and racial/ethnic differencesMesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation.Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study.Subsequent malignant neoplasms after hematopoietic cell transplantation.Second malignancies in patients with primary central nervous system lymphoma.Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantationStem cell transplantation in follicular lymphoma: progress at last?Survival of patients who develop solid tumors following hematopoietic stem cell transplantation.Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challengesIncreased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant researchFrequent induction of chromosomal aberrations in in vivo skin fibroblasts after allogeneic stem cell transplantation: hints to chromosomal instability after irradiation.
P2860
Q24200521-D0252EBD-D1E9-41DD-AFA3-850E8F9533F5Q24234049-55557233-891E-43F4-9774-9654B219FE01Q26852687-F7A9FC28-134C-461A-80D2-4F7956E828DCQ26991532-6DE40673-B69C-4F51-8A0F-A20C4578A12CQ28088369-08B09BC2-3C51-403B-9583-52C6CAA0D227Q29248394-378C9B18-8482-4EB9-A920-9AD18B980789Q30248284-D034823F-7F59-46BB-A355-F65D3C40AF02Q30355135-50E48515-40EF-4D26-B9AB-8272759486EFQ33387312-05D548D1-90C9-48F0-A966-CB57CC33464DQ33558770-2A7EEBFE-7804-4FDD-9DDA-4547EE446E8EQ33583099-5F5D5605-2488-435D-A6D2-3109CA929377Q33680218-34883AB1-F57C-4028-8C68-9F391316027FQ33836091-90B9397E-5726-4D71-97E1-1C4C15BE78A4Q33870603-3FFD4520-C992-4C09-A130-A1710DB0655CQ33952705-56A14A0C-688C-4AA5-B88B-3E96D8D60684Q34095701-A55D0615-B35F-4FA1-ADE3-6A8B8B398FA1Q34127657-89F47E27-53EC-4720-A2F8-EEAA1E2CCD9DQ34325244-32C15E2E-4DB7-45B5-8438-83E8C75B4D98Q34422543-073F0F7B-C53E-4342-A06E-5D70ED3DEED2Q34554733-77504169-B33F-4692-8DFF-D59E41FC7A70Q34568905-E996A97E-886D-43FB-B191-3DDEA7CF5A45Q34668052-52106CEC-93E3-4ACE-BC70-6534C16E045EQ34788603-8FAED85D-504E-498B-A613-F752C502891CQ34939208-2C5F1638-A088-44DC-8E35-5DBA43274D7FQ35036840-7B6F41AA-2EAA-4AFF-8CED-F0B0814CF652Q35085747-D21BEBA1-CB01-4DE8-93DF-5B818DCF456FQ35098364-BEFFC702-46B8-4D6F-B7FD-62CD6481B61DQ35136616-628145CE-C9D3-4B91-8ECD-65034F1E167EQ35677669-3C68D64E-ED0B-4DCC-8715-1F7FDDA59976Q35678455-9A9ABC3F-BBDD-4D18-84F0-A2E1C5FCA895Q35788720-AE935AC0-A6CB-4380-B9CC-1D1E94770727Q35847602-84FFF401-B8B1-4AA4-B1E0-67891D8586BFQ35848160-C3E6A4E6-BB05-4517-BACD-CC88285653D1Q35920882-9E54E6D6-6A5D-4520-97AB-FD75A37A2D7AQ36060706-13E830E8-37B1-4380-A12F-29E8C873D716Q36078279-A4FAB6E3-E99F-4C6B-A744-07FF287BB3BAQ36266642-B9DE5A51-C535-4131-B2FD-AB15339A79E5Q36384739-3918431B-4922-42F6-9527-3B75663155BAQ36395151-FD380F84-92ED-4E4D-B095-CB89FC92A9E8Q36416779-A49D147D-AF00-4FE2-835C-12D3E2A25651
P2860
New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
New malignancies after blood o ...... s: incidence and risk factors.
@en
New malignancies after blood o ...... s: incidence and risk factors.
@nl
type
label
New malignancies after blood o ...... s: incidence and risk factors.
@en
New malignancies after blood o ...... s: incidence and risk factors.
@nl
prefLabel
New malignancies after blood o ...... s: incidence and risk factors.
@en
New malignancies after blood o ...... s: incidence and risk factors.
@nl
P2093
P356
P1476
New malignancies after blood o ...... s: incidence and risk factors.
@en
P2093
Joseph P Neglia
K Scott Baker
Leslie L Robison
Linda J Burns
Norma K C Ramsay
Todd E DeFor
P304
P356
10.1200/JCO.2003.05.108
P407
P577
2003-04-01T00:00:00Z